Avita Medical is a medical device company that provides a unique approach to skin regeneration



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Our patented and proprietary collection and application technology provides innovative treatment solutions derived from a patient’s own skin to treat a wide range of wounds, scars and skin defects. Our devices create a Regenerative Epithelial Suspension (RES™) – an autologous suspension comprised of the cells and wound healing factors necessary to regenerate natural healthy skin.

Avita’s regenerative product portfolio includes ReCell® for burns aimed at plastic reconstructive procedures, ReGenerCell™ for chronic wounds and ReNovaCell™ for the restoration of pigmentation.

Read more



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Read more


7,329

Procedures

32

Market Approvals

64

Published Papers

47%

reduction in hospital stay20

38%

reduction in donor skin21

ReCell® is a medical device that enables medical professionals to collect cells from a small sample of a patient’s own skin to create a suspension that can regenerate wounds caused by burns.

55%

reduction in wound area in 4 weeks2

33%

pain reduction in one week7

ReGenerCell™ is a medical device that allows medical professionals to swiftly create a suspension of skin cells that can trigger healing in chronic wounds, such as venous leg ulcers and diabetic foot ulcers.

78%

re-pigmentation2

reduced

healing time, risk of infection and scarring4,6,7

ReNovaCell™ is a medical device that delivers a skin cell suspension for treating aesthetic applications: restoring pigmentation, and improving the appearance of scars, sun-damaged skin, wrinkles and lesions.

Twitter

follow

Tuesday, December 13th, 2016 at 11:21am
Bioshares interview between CEO, Adam Kelliher and David Blake in Melbourne.
https://t.co/vMN4zetMwC
Wednesday, November 30th, 2016 at 1:41pm
Avita Medical and our Malaysian distributor, Mintcare, conducting an introductory workshop at Malaysia largest public hospital, Hospital KL. https://t.co/M5BnVwiNCS AvitaMedical photo
1
Wednesday, November 30th, 2016 at 1:38pm
Avita Medical and our Malaysian distributor, Mintcare, presenting at the Melaka 1st Burn Update 2016. https://t.co/EbIrFrKumb AvitaMedical photo

Facebook

follow

Avita Medical
Avita MedicalWednesday, December 14th, 2016 at 11:35pm

@MediaplanetUK launches the 2016 Wound Care campaign. Read all about improved treatments, diagnosis and importance of effective wound care and management http://bit.ly/2gwpsOV

Avita Medical
Avita MedicalTuesday, December 13th, 2016 at 2:22pm

Bioshares interview between CEO, Adam Kelliher and David Blake in Melbourne.
http://3af4pk1d7ktnf8ieb2pl91t1.wpengine.netdna-cdn.com/wp-content/uploads/2016/12/Bioshares677-002.pdf

Share Price

Last Trade: 0.115 Last Trade: 1.71
High: 0.115 High: 1.75
Low: 0.115 Low: 1.7
Close: 0.115 Close: 1.71
Volume: 71,623 Volume: 21620
Prices are delayed by 20 minutes